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Introduction
CiCVVH has become standard treatment for on ICU
with AKI. Though regional citrate anticoagulation for
CRRT is recommended as first line therapy in the AKI
guideline by the KDIGO Group, IHD is practised in
many ICU patients with AKI. Evidence for superiority for
one technique over the other remains equivocal, though
there is increasing evidence for better renal function pre-
servation in CVVH. However, there is also evidence for
increased non-recovering of renal function in ICU
patients with AKI who have hypomagnesemia.
Objectives
Goal is to compare magnesium profiles of ICU patients
requiring RRT, treated with either ciCVVH or IHD.
Methods
Over a 12 month period ICU patients were retrospec-
tively studied for cases of AKI requiring RRT. Treatment
episodes with ciCVVH (n=38) were compared to those
treated with IHD (n=18 ). A number of patients under-
went both ciCVVH and IHD. All magnesium values were
analyzed from 12 hrs after initiation of RRT until cessa-
tion. Feeding in ICU patients is protocol-based and,
though tailored to the diagnosis of AKI, does not differ
based on mode of RRT. Magnesium supplementation gen-
erally takes place where values drop below 0.7 mmol/L.
The substitution fluid used in ciCVVH contains
0.75 mmol/L. IHD fluids are magnesium free.
Results
437 Magnesium values for patients on ciCVVH were
analyzed (62.2%), 256 for IHD (36.4%). Magnesium
values were significantly different in the 2 groups (mean
(ciCVVH)=0,70 mmol/L, SD=0,22; mean (IHD) =
0.99 mmol/L, SD=0,20; p < 0,001). In ciCVVH, 265 of
437(61%) were below the normal threshold (normal
values 0.7-0.9 mmol/L), in the IHD only 9 out of
256 (4%). Six values in the ciCVVH group were below
0.4 mmol/L, the threshold for severe hypomagnesemia,
none in the IHD group.
Conclusions
Magnesium values for patients on ciCVVH are significantly
lower than IHD despite use of a Magnesium containing
substitiion fluid. Dangerous values of hypomagnesemia can
occur in ciCVVH. Review of magnesium testing and sup-
plementation regimens in the ciCVVH group is warranted.
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